FSCN1 and colorectal carcinoma: In CRC, miR-451 has also been proven to mediate FSCN1 expression by inhibiting 5′ AMP-activated protein kinase (AMPK) when overexpressed, which in turn activates the mammalian target of rapamycin (mTOR) that is capable of regulating FSCN1 [29].